The FDA permitted Wilson-Cook Medical to market Hemospray, a new endoscopic device for the treatment of gastrointestinal bleeding.
The FDA approved Salix Pharmaceuticals’ Plenvu lower-volume polyethylene glycol-based bowel preparation.
Libertyville-based GI Partners of Illinois and Cumming, Ga.-based GI North both switched to the gGastro EHR system by gMed, a Modernizing Medicine company.
Olympus entered a co-development agreement with ai4gi to offer the artificial intelligence solution for real-time clinical decision support during screening and surveillance colonoscopy.
GI Supply’s Spot Ex Endoscopic Tattoo received CE mark approval and launched in Europe.
More articles on gastroenterology:
Hoag Orthopedic Institute hosts 1st mock surgery event — 5 highlights’
Envision to transition 95% of revenue in-network by the end of 2018
Envision blames ambulatory revenue drop on flu, sees Q2 recovery: 5 things to know from Q1
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.